Dundee, Scotland, 27 August 2008: Axis-Shield plc (LSE:ASD, OSE:ASD), the international in vitro diagnostics company, today announces that it is developing a full lipid test panel for its award-winning Afinion™ Point-of-Care System, as an aid to cardiovascular risk assessment. The test panel will measure HDL and LDL-cholesterol and triglycerides, as well as total cholesterol and is expected to be launched in 2011.
